Active	Status	Sponsor type	Region	Phase	Filter
6 Active 1 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sun, Yuqian
OASIS, NCT05101187: Olorofim Aspergillus Infection Study	Recruiting	3	225	Europe, Canada, Japan, US, RoW	Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B)	F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi	Invasive Aspergillosis	09/25	11/26
NCT06439342: A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections	Not yet recruiting	3	20	RoW	Maribavir, TAK-620	Takeda	Cytomegalovirus (CMV)	02/27	02/27
NCT06674382: Haplo-HSCT for Myelofibrosis	Recruiting	N/A	39	RoW	Haploidentical hematopoietic stem cell transplantation	Peking University People's Hospital	Myelofibrosis	12/27	12/27
NCT05902416: Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome	Recruiting	N/A	120	RoW		Peking University People's Hospital	Acute Leukemia, Myelodysplastic Syndromes	06/25	12/26
NCT06583512: Treatment Duration of IPA	Active, not recruiting	N/A	15	RoW		Peking University People's Hospital	Invasive Aspergillosis, Antifungal Therapy	08/25	08/26
NCT05149547: mNGS Versus Blood Culture in FN	Recruiting	N/A	300	RoW	blood culture versus mNGS detection	Peking University People's Hospital, Peking University First Hospital, Peking University International Hospital, Hebei Yanda Ludaopei Hospital	Infections, Hematologic Diseases, Febrile Neutropenia	05/22	08/22